logo

For the Inventor, By the Inventor

Titusville, NJ, United States of America

Rudiger D Haugwitz

USPTO Granted Patents = 42

Average Co-Inventor Count = 2.0

ph-index = 8

Forward Citations = 232(Granted Patents)


Company Filing History:

goldMedal42 out of 1,624 
 
E. R. Squibb Sons, Inc.
 patents

Years Active: 1976-1987

Loading Chart...
Areas of Expertise:
Phenoxy Prolines
Thio Androstenes
Benzothiadiazines
Dithioacyldihydropyrazole
Phenylguanidines
Lactam Derivatives
Selenium Derivatives
Benzimidazole Carbamates
Indantetrol Derivatives
Isothiocyanobenzoxazoles
Anthelmintic Compounds
Pyridine Derivatives
42 patents (USPTO):Explore Patents
1. 4681886 - Substituted 4-phenoxy or 4-phenylthio prolines (1987-07-21),
2. 4536501 - Substituted 4-phenoxy or 4-phenylthio prolines (1985-08-20),
3. 4529548 - 17.beta.-(substituted thio)androstenes (1985-07-16),
4. 4338435 - Benzothiadiazines having diuretic activity (1982-07-06),
5. 4331806 - Dithioacyldihydropyrazole carboxylic acid derivatives (1982-05-25),
6. 4328241 - Substituted phenylguanidines and method (1982-05-04),
7. 4312990 - 1-Mercaptoacyl-3-[(aminosulfonyl) (1982-01-26),
8. 4312809 - Lactam derivatives of mercaptoacylamino acids (1982-01-26),
9. 4293569 - Substituted phenylguanindines and method (1981-10-06),
10. 4288368 - Dithioacylproline derivatives (1981-09-08),
11. 4221796 - Substituted imidazolo-pyridines and method (1980-09-09),
12. 4218396 - Phenylene-bis (substituted thioureas) (1980-08-19),
13. 4217358 - Substituted phenylguanidines and method (1980-08-12),
14. 4196250 - Polyether derivatives (1980-04-01),
15. 4181663 - Selenium containing derivatives of proline and pipecolic acid (1980-01-01),

Title: The Innovative Contributions of Rudiger D. Haugwitz

Introduction: Rudiger D. Haugwitz is a distinguished inventor based in Titusville, NJ, whose work has significantly impacted the field of pharmaceuticals. With a remarkable portfolio of 42 patents, his innovative approaches have addressed important health issues, particularly in the development of antihypertensive agents.

Latest Patents: Among his noteworthy contributions are his recent patents focused on substituted 4-phenoxy and 4-phenylthio prolines. These compounds exhibit useful hypotensive activity and are essential in the treatment of hypertension. Specifically, his inventions outline the properties of these prolines, highlighting their angiotensin-converting enzyme inhibition activity and diuretic effectiveness, which positions them as valuable antihypertensive agents.

Career Highlights: Haugwitz's successful career is anchored at E.R. Squibb & Sons, Inc., where he has played a pivotal role in advancing pharmaceutical research. His extensive experience in the field has enabled him to contribute significantly to innovations that improve health outcomes for patients suffering from hypertension.

Collaborations: Throughout his career, Haugwitz has collaborated with talented colleagues, including Venkatachala L. Narayanan and Larry R. Cruthers. These partnerships have fostered a rich environment for creative problem-solving and the advancement of research and development initiatives within the company.

Conclusion: Rudiger D. Haugwitz's dedication to innovation in pharmaceuticals has established him as a leading inventor in his field. His contributions, particularly in developing compounds aimed at managing hypertension, demonstrate the vital role of research and collaboration in driving health advancements. With a strong foundation of patents and collaborative efforts, Haugwitz continues to influence the future of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…